Found: 10
Select item for more details and to access through your institution.
Immunopathogenesis and therapy of cutaneous T cell lymphoma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Synthetic Imidazoquinolines Potently and Broadly Activate the Cellular Immune Response of Patients with Cutaneous T-Cell Lymphoma: Synergy with Interferon-γ Enhances Production of Interleukin-12.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 8, p. 524
- By:
- Publication type:
- Article
CD164 and FCRL3 Are Highly Expressed on CD4+CD26− T Cells in Sézary Syndrome Patients.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 1, p. 229, doi. 10.1038/jid.2013.279
- By:
- Publication type:
- Article
IL-31 Is Produced by the Malignant T-Cell Population in Cutaneous T-Cell Lymphoma and Correlates with CTCL Pruritus.
- Published in:
- Journal of Investigative Dermatology, 2013, v. 133, n. 12, p. 2783, doi. 10.1038/jid.2013.227
- By:
- Publication type:
- Article
IL-21 Enhances Antitumor Responses without Stimulating Proliferation of Malignant T Cells of Patients with Sézary Syndrome.
- Published in:
- Journal of Investigative Dermatology, 2008, v. 128, n. 2, p. 473, doi. 10.1038/sj.jid.5701027
- By:
- Publication type:
- Article
A Role for Regulatory T Cells in Cutaneous T-Cell Lymphoma; Induction of a CD4+CD25+Foxp3+ T-Cell Phenotype Associated with HTLV-1 Infection.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Failure to Detect Human T-Lymphotropic Virus Type-I Proviral DNA in Cell Lines and Tissues from Patients with Cutaneous T-Cell Lymphoma.
- Published in:
- Journal of Investigative Dermatology, 1996, v. 107, n. 3, p. 308, doi. 10.1111/1523-1747.ep12363017
- By:
- Publication type:
- Article
Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: Implications for therapy of cutaneous T-cell lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 2, p. 226, doi. 10.1002/ajh.22231
- By:
- Publication type:
- Article
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: Reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 9, p. 792, doi. 10.1002/ajh.20952
- By:
- Publication type:
- Article
The use of cytokines, fusion proteins and antibodies to treat cutaneous T-cell lymphoma.
- Published in:
- Dermatologic Therapy, 2003, v. 16, n. 4, p. 331, doi. 10.1111/j.1396-0296.2003.01645.x
- By:
- Publication type:
- Article